首页> 外文期刊>Experimental & molecular medicine. >Suppression of Aurora-A oncogenic potential by c-Myc downregulation
【24h】

Suppression of Aurora-A oncogenic potential by c-Myc downregulation

机译:c-Myc下调抑制Aurora-A致癌潜力

获取原文
       

摘要

The abnormality of serine/threonine kinase Aurora-A is seen in many types of cancers. Although in physiological context it has been shown to play a vital role in cellular mitosis, how this oncogene contributes to tumorigenesis remains unclear. Here we demonstrate that Aurora-A overexpression enhances both the expression level and transcriptional activity of c-Myc. The inhibition of c-Myc expression by RNA interference significantly impaired the oncogenic potential of Aurora-A, resulting in attenuated cellular proliferation and transformation rates as well as fewer centrosomal aberrations. Furthermore, downregulation of c-Myc effectively overcame Aurora-A-induced resistance to cisplatin in esophageal cancer cells. Taken together, our results suggest an important role for c-Myc in mediating the oncogenic activity of Aurora-A, which may in turn allow for future targeting of c-Myc as a potential therapeutic strategy for tumors with Aurora-A overexpression.
机译:在许多类型的癌症中都可以看到丝氨酸/苏氨酸激酶Aurora-A的异常。尽管在生理学上已证明它在细胞有丝分裂中起着至关重要的作用,但尚不清楚该致癌基因如何促进肿瘤发生。在这里,我们证明了Aurora-A的过表达增强了c-Myc的表达水平和转录活性。 RNA干扰对c-Myc表达的抑制作用显着削弱了Aurora-A的致癌潜力,从而导致细胞增殖和转化率降低以及中心体畸变减少。此外,c-Myc的下调有效地克服了食管癌细胞中Aurora-A诱导的对顺铂的耐药性。两者合计,我们的结果表明c-Myc在介导Aurora-A的致癌活性中起着重要作用,这反过来又可能使将来将c-Myc靶向作为具有Aurora-A过表达的肿瘤的潜在治疗策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号